380 related articles for article (PubMed ID: 29669806)
1. Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.
Gavvovidis I; Leisegang M; Willimsky G; Miller N; Nghiem P; Blankenstein T
Clin Cancer Res; 2018 Aug; 24(15):3644-3655. PubMed ID: 29669806
[No Abstract] [Full Text] [Related]
2. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
[TBL] [Abstract][Full Text] [Related]
4. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
[TBL] [Abstract][Full Text] [Related]
5. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
[TBL] [Abstract][Full Text] [Related]
6. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
Colunga A; Pulliam T; Nghiem P
Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
[TBL] [Abstract][Full Text] [Related]
7. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
[TBL] [Abstract][Full Text] [Related]
8. Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.
Willmes C; Adam C; Alb M; Völkert L; Houben R; Becker JC; Schrama D
Cancer Res; 2012 Apr; 72(8):2120-8. PubMed ID: 22389452
[TBL] [Abstract][Full Text] [Related]
9. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
[TBL] [Abstract][Full Text] [Related]
10. Survivin is a therapeutic target in Merkel cell carcinoma.
Arora R; Shuda M; Guastafierro A; Feng H; Toptan T; Tolstov Y; Normolle D; Vollmer LL; Vogt A; Dömling A; Brodsky JL; Chang Y; Moore PS
Sci Transl Med; 2012 May; 4(133):133ra56. PubMed ID: 22572880
[TBL] [Abstract][Full Text] [Related]
11. Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model.
Shuda M; Guastafierro A; Geng X; Shuda Y; Ostrowski SM; Lukianov S; Jenkins FJ; Honda K; Maricich SM; Moore PS; Chang Y
PLoS One; 2015; 10(11):e0142329. PubMed ID: 26544690
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.
Houben R; Dreher C; Angermeyer S; Borst A; Utikal J; Haferkamp S; Peitsch WK; Schrama D; Hesbacher S
J Invest Dermatol; 2013 Oct; 133(10):2453-2460. PubMed ID: 23563200
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.
Angermeyer S; Hesbacher S; Becker JC; Schrama D; Houben R
J Invest Dermatol; 2013 Aug; 133(8):2059-64. PubMed ID: 23439392
[TBL] [Abstract][Full Text] [Related]
14. Robust Production of Merkel Cell Polyomavirus Oncogene Specific T Cells From Healthy Donors for Adoptive Transfer.
Davies SI; Barrett J; Wong S; Chang MJ; Muranski PJ; Brownell I
Front Immunol; 2020; 11():592721. PubMed ID: 33362774
[TBL] [Abstract][Full Text] [Related]
15. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.
Amber K; McLeod MP; Nouri K
Dermatol Surg; 2013 Feb; 39(2):232-8. PubMed ID: 23387356
[TBL] [Abstract][Full Text] [Related]
16. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus.
Shuda M; Feng H; Kwun HJ; Rosen ST; Gjoerup O; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16272-7. PubMed ID: 18812503
[TBL] [Abstract][Full Text] [Related]
17. Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Nwogu N; Ortiz LE; Whitehouse A; Kwun HJ
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669331
[TBL] [Abstract][Full Text] [Related]
18. Human CD4
Longino NV; Yang J; Iyer JG; Ibrani D; Chow IT; Laing KJ; Campbell VL; Paulson KG; Kulikauskas RM; Church CD; James EA; Nghiem P; Kwok WW; Koelle DM
Cancer Immunol Res; 2019 Oct; 7(10):1727-1739. PubMed ID: 31405946
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice.
Guastafierro A; Feng H; Thant M; Kirkwood JM; Chang Y; Moore PS; Shuda M
J Virol Methods; 2013 Jan; 187(1):6-14. PubMed ID: 23085629
[TBL] [Abstract][Full Text] [Related]
20. Merkel Cell Carcinomas Arising in Autoimmune Disease Affected Patients Treated with Biologic Drugs, Including Anti-TNF.
Rotondo JC; Bononi I; Puozzo A; Govoni M; Foschi V; Lanza G; Gafà R; Gaboriaud P; Touzé FA; Selvatici R; Martini F; Tognon M
Clin Cancer Res; 2017 Jul; 23(14):3929-3934. PubMed ID: 28174236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
